Sung-Sun Cho
Algemeen Directeur bij YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.
Actieve functies van Sung-Sun Cho
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - |
Loopbaan van Sung-Sun Cho
Eerdere bekende functies van Sung-Sun Cho
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Algemeen Directeur | - | - |
Statistieken
Internationaal
| Zuid-Korea | 3 |
Operationeel
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Beurs
- Insiders
- Sung-Sun Cho
- Ervaring
